Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

Medical Imaging Corp. (OTCMKTS:MEDD – Get Free Report)’s share price passed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.00 and traded as ...

Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP ...

Presenting their top academic honors for 2025, the Academic Senate and Federation recognize and showcase faculty not just for ...

Longeveron (LGVN) announced the publication in Nature Medicine of results from the CLEAR MIND Phase 2a clinical trial evaluating laromestrocel ...

Mellencamp’s cancer journey began in March 2022 when she took to Instagram to reveal that she’d had a suspicious mole removed ...

Learn more about whether GE HealthCare Technologies Inc. or IDEXX Laboratories, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The global perfusion imaging market is on a trajectory of robust growth, with market revenues expected to rise from USD 2,421.4 million in 2024 to nearly USD 3,382.8 million by 2034. According to a ...

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...

Phase 2a results demonstrated laromestrocel (Lomecel-B) improved cognitive function, quality of life, and brain volume in the treatment of mild Alzheimer's diseaseThis encouraging clinical trial data ...